Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

Ann Intern Med. 2004 Mar 2;140(5):404-6. doi: 10.7326/0003-4819-140-5-200403020-00025.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Behcet Syndrome / drug therapy*
  • Female
  • Humans
  • Inflammation / drug therapy
  • Infliximab
  • Male
  • Middle Aged
  • Prospective Studies
  • Recurrence
  • Retinal Vasculitis / drug therapy
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Visual Acuity
  • Vitreous Body

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab